As of January 2026, the China Leigh Syndrome treatment market is identifying as a specialized but rapidly accelerating segment of the rare disease sector, with a valuation projected to reach approximately $10 million this year. The 2026 landscape is defined by the peak implementation of the National Rare Disease Registry System, which has identified over 1,500 Leigh Syndrome cases across China,...